Age of AI Canada, 2025
June 17, 2025 · Globe & Mail, Toronto
A year of AI innovation packed into one day!
Daniel Smedley
Vice President, Innovation, Business Excellence and IT (Canada) · AstraZeneca
Daniel Smedley
Vice President, Innovation, Business Excellence and IT (Canada)
AstraZeneca
Daniel Smedley is the Vice President of Innovation & Business Excellence (IBEX) and IT for AstraZeneca Canada Inc., one of Canada’s leading biopharmaceutical companies. A proven senior business and people leader, Daniel has more than 15 years Global and Canadian experience across a number of finance functions, including financial planning & analysis, controllership and decision support within the biopharmaceutical, medical and hospital industries.
Sessions
Daniel Smedley
10:10 AM – 10:40 AM
PAAB and AstraZeneca: Why Strategic Partnerships Are Crucial for AI Success
- Get an exclusive update on PAAB’s proprietary AI solution.
- Discover why AstraZeneca saw this partnership as an opportunity to improve the overall approval process.
- Learn which stakeholders were engaged and how objections were overcome at both local and global levels.
Daniel Smedley , Vice President, Innovation, Business Excellence and IT (Canada), AstraZeneca
Jennifer Carroll, Director of Communications, PAAB